The transcript level of interleukin-6 in the cartilage of idiopathic osteoarthritis of knee

Clinica Terapeutica

Volumn 161, Issue 1, 2010, Pages 25-28

  Mokhtar, Norfilza Mohd ^a   Yusof, H M ^a   Yahaya, N H M ^a   Muhamad, R ^a   Das, S ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Cartilage; Interleukin 6; Knee; mRNA; Osteoarthritis; Real time PCR

Indexed keywords

BETA ACTIN; INTERLEUKIN 6; MESSENGER RNA;

ADULT; ARTICLE; CARTILAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; IDIOPATHIC DISEASE; KNEE OSTEOARTHRITIS; REAL TIME POLYMERASE CHAIN REACTION; TIBIOFEMORAL CARTILAGE;

ALGORITHMS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; HUMANS; INTERLEUKIN-6; OSTEOARTHRITIS, KNEE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 77950286141     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Xie F, Thumboo J, Fong KY, et al. Direct and indirect costs of osteoarthritis in Singapore: a comparative study among multiethnic Asian patients with osteoarthritis. J Rheumatol 2007; 34:165-171
2. Veerapen K, Wigley RD, Valkenburg H. Musculoskeletal pain in Malaysia: a COPCORD survey. J Rheumatol 2007; 34:207-213
3. van der Kraan PM, van den Berg WB. Anabolic and destructive mediators in osteoarthritis. Curr Opin Clin Nutr Metab Care 2000; 3:205-211
4. Blom AB, van der Kraan PM, van den Berg WB. Cytokine targeting in osteoarthritis. Curr Drug Targets 2007; 8:283-92
5. Kwan Tat S, Padrines M, Théoleyre S, et al. IL-6, RANKL, TNF-alpha/IL-1 : interrelations in bone reabsorption pathophysiology. Cytokine Growth Factor Rev 2004; 15:49-60
6. Doss F, Menard J, Hauschild M, et al. Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells. Scand J Rheumatol 2007; 36:136-139
7. Sakao K, Takahashi KA, Mazda O, et al. Enhanced expression of interleukin-6, matrix metalloproteinase-13, and receptor activator of NF-kappaB ligand in cells derived from osteoarthritic subchondral bone. J Orthop Sci 2008; 13:202-210
8. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000; 6:71-79
9. Blanchard F, Duplomb L, Baud'huin M, et al. The dual role of IL-6-type cytokines on bone remodeling and bone tumors. Cytokine Growth Factor Rev 2009; 20:19-28
10. de Hooge AS, van de Loo FA, Bennink MB, et al. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging. Osteoarthritis Cartilage 2005; 13:66-73
11. Guerne PA, Desgeorges A, Jaspar JM, et al. Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone. Matrix Biol 1999; 18:253-260
12. Mathy-Hartert M, Hogge L, Sanchez C, et al. Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation. Osteoarthritis Cartilage 2008; 16:756-763
13. Krasnokutsky S, Samuels J, Abramson SB. Osteoarthritis in 2007. Bull NYU Hosp Jt Dis 2007; 65:222-228
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408
15. Iliopoulos D, Malizos KN, Oikonomou P, et al. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE 2008; 3:e3740
16. Honorati MC, Cattini L, Facchini A. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cartilage 2004; 12:683-691
17. Ota N, Nakajima T, Nakazawa I, et al. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 2001; 46:267-272
18. Koyama Y, Mitsui N, Suzuki N, et al. Effect of compressive force on the expression of inflammatory cytokines and their receptors in osteoblastic Saos-2 cells. Arch Oral Biol 2008; 53:488-496
19. Linkhart TA, Linkhart SG, MacCharles DC, et al. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1. J Bone Miner Res 1991; 6:1285-1294
20. Holt I, Davie MW, Braidman IP, et al. Prostaglandin E2 stimulates the production of interleukin-6 by neonatal mouse parietal bones. Bone Miner 1994; 25:47-57
21. Franchimont N, Wertz S, Malaise M. Interleukin-6: An osteotropic factor influencing bone formation? Bone 2005; 37:601-606
22. van de Loo FA, Kuiper S, van Enckevort FH, et al. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. Am J Pathol 1997; 151:177-191
23. Miggiano GA, Gagliardi L. Diet, nutrition and rheumatoid arthritis Clin Ter 2005; 156:115-123